Mike Hay
About Mike Hay
Mike Hay is a Principal Scientist at Bristol-Myers Squibb and an Associate Director at Sage Therapeutics, with extensive experience in the pharmaceutical industry.
Current Roles in the Pharmaceutical Industry
Mike Hay currently holds the position of Principal Scientist at Bristol-Myers Squibb. Additionally, he serves as a Senior Research Investigator II, a role also based in New York, New York. Complementing these responsibilities, Mike joined Sage Therapeutics in July 2021 as an Associate Director. His multiple roles indicate a strong presence and significant contributions in the pharmaceutical sector.
Past Positions and Industry Experience
Mike Hay has a rich background in the pharmaceutical industry. He worked as a Research Investigator at Bristol-Myers Squibb from 2008 to 2010. Early in his career, he gained valuable experience through co-op positions at Johnson & Johnson in 2002 and McNeil Consumer Healthcare in 2000. These early roles provided him with a foundational understanding of the industry.
Educational Background in Chemistry
Mike Hay pursued advanced education in chemistry, earning a Ph.D. in Organic Chemistry from the University of Michigan, where he studied from 2002 to 2007. Prior to this, he achieved a Bachelor's degree (BS) in Chemistry from Penn State University, completing his studies from 1997 to 2002. His academic background has been instrumental in shaping his expertise and career in the pharmaceutical field.
Career at Bristol-Myers Squibb
Throughout his career at Bristol-Myers Squibb, Mike Hay has taken on multiple roles, reflecting his growth and versatility within the organization. He began as a Research Investigator from 2008 to 2010, later advancing to positions such as Principal Scientist and Senior Research Investigator II. His long-term affiliation with Bristol-Myers Squibb signifies a deep level of involvement and contribution.
Role at Sage Therapeutics
In July 2021, Mike Hay joined Sage Therapeutics as an Associate Director. This role at Sage Therapeutics aligns with his extensive experience in the pharmaceutical industry and underscores his capabilities in leadership and scientific research. His position at Sage Therapeutics adds a new dimension to his already diverse professional portfolio.